Wave Life Sciences Misses Expectations in Q3
Update: 2025-11-10
Description
Wave Life Sciences reports a significant loss of $53.9 million, or $0.32 per share, in Q3, falling short of analysts predictions of a $0.30 loss per share. Revenue also missed expectations, coming in at $7.6 million instead of the projected $13 million. This underperformance raises concerns for investors and the market, with plans for improvement expected in upcoming quarters.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
